Australia markets closed

Bio-Rad Laboratories, Inc. (BIO-B)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
279.910.00 (0.00%)
As of 03:59PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 7.88B
Enterprise value 7.68B
Trailing P/E N/A
Forward P/E 25.13
PEG ratio (5-yr expected) 1.06
Price/sales (ttm)3.06
Price/book (mrq)0.91
Enterprise value/revenue 2.88
Enterprise value/EBITDA -11.73

Trading information

Stock price history

Beta (5Y monthly) 0.88
52-week change 3-39.69%
S&P500 52-week change 321.08%
52-week high 3467.95
52-week low 3271.00
50-day moving average 3328.24
200-day moving average 3337.71

Share statistics

Avg vol (3-month) 3275
Avg vol (10-day) 350
Shares outstanding 55.1M
Implied shares outstanding 628.97M
Float 819.96M
% held by insiders 197.55%
% held by institutions 10.07%
Shares short (15 Apr 2024) 411
Short ratio (15 Apr 2024) 40.58
Short % of float (15 Apr 2024) 40.01%
Short % of shares outstanding (15 Apr 2024) 40.00%
Shares short (prior month 15 Mar 2024) 412

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 308 Mar 2002

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -23.86%
Operating margin (ttm)14.24%

Management effectiveness

Return on assets (ttm)1.77%
Return on equity (ttm)-6.94%

Income statement

Revenue (ttm)2.67B
Revenue per share (ttm)91.45
Quarterly revenue growth (yoy)-6.70%
Gross profit (ttm)N/A
EBITDA 511.6M
Net income avi to common (ttm)-637.32M
Diluted EPS (ttm)-21.83
Quarterly earnings growth (yoy)-57.80%

Balance sheet

Total cash (mrq)1.61B
Total cash per share (mrq)56.35
Total debt (mrq)1.41B
Total debt/equity (mrq)16.08%
Current ratio (mrq)5.83
Book value per share (mrq)306.51

Cash flow statement

Operating cash flow (ttm)374.9M
Levered free cash flow (ttm)170.82M